The spot is a clear violation of the FDCA, which requires that advertising for prescription drugs including compounded drugs not be false or misleading, contended Pharmaceutical Research and Manufacturers of America (PhRMA), whose public affairs team invited reporters to reach out if you have any questions. Its clearly an ad to sell a prescription drug, added Shabbir Safdar, executive director of watchdog group Partnership for Safe Medicines, of Hims spot
Tirzepatide (Mounjaro/Zepbound), a dual GLP-1/GIP agonist, shows superior efficacy in head-to-head trials, see our tirzepatide vs semaglutide comparison
Track shots, weight, symptoms, menstrual cycles, meals, and notes in one place, with a workflow designed for steady weekly use
Available exclusively at Revital Trichology & Wellness, Mumbai Book your consultation today and begin your personalized peptide therapy journey in India.